BCLSI
Bain Capital Life Sciences Investors Portfolio holdings
AUM
$799M
This Quarter Return
+9.6%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$961M
AUM Growth
+$961M
(+5.5%)
Cap. Flow
+$2.09M
Cap. Flow
% of AUM
0.22%
Top 10 Holdings %
Top 10 Hldgs %
89.37%
Holding
26
New
1
Increased
5
Reduced
1
Closed
2
Top Buys
| 1 |
Cidara Therapeutics
CDTX
|
$7.56M |
| 2 |
Cabaletta Bio
CABA
|
$5.24M |
| 3 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
$749K |
| 4 |
Xilio Therapeutics
XLO
|
$615K |
| 5 |
Annexon
ANNX
|
$3.2K |
Top Sells
| 1 |
Arcutis Biotherapeutics
ARQT
|
$9.59M |
| 2 |
Tango Therapeutics
TNGX
|
$1.39M |
| 3 |
Aclaris Therapeutics
ACRS
|
$1.1M |
Sector Composition
| 1 | Healthcare | 99.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Nuvalent
NUVL
$5.52B
| $276M | 28.71% | 2,697,267 | – | – |
|
2
NewAmsterdam Pharma
NAMS
$2.71B
| $174M | 18.09% | 10,473,913 | – | – |
|
3
Disc Medicine
IRON
$2.07B
| $88.2M | 9.18% | 1,795,735 | – | – |
|
4
Dianthus Therapeutics
DNTH
$759M
| $82.5M | 8.58% | 3,013,423 | – | – |
|
5
Savara
SVRA
$567M
| $61.8M | 6.43% | 14,565,457 | – | – |
|
6
Pharvaris
PHVS
$1.39B
| $61.2M | 6.37% | 3,303,381 | – | – |
|
|
7
Annexon
ANNX
$226M
| $50M | 5.2% | 8,449,748 +540 | +0% | +$3.2K |
|
8
Solid Biosciences
SLDB
$427M
| $28.1M | 2.93% | 4,034,582 | – | – |
|
|
9
Tango Therapeutics
TNGX
$747M
| $20.9M | 2.17% | 2,712,008 -180,655 | -6% | -$1.39M |
|
10
Kyverna Therapeutics
KYTX
$160M
| $16.5M | 1.71% | 3,368,370 | – | – |
|
11
Mersana Therapeutics
MRSN
$36.5M
| $16.4M | 1.7% | 8,663,673 | – | – |
|
|
12
Cabaletta Bio
CABA
$133M
| $13M | 1.36% | 2,760,888 +1,110,924 | +67% | +$5.24M |
|
13
X4 Pharmaceuticals
XFOR
$84.2M
| $11.3M | 1.18% | 16,915,784 | – | – |
|
14
Century Therapeutics
IPSC
$42.5M
| $9.25M | 0.96% | 5,410,361 | – | – |
|
15
Atea Pharmaceuticals
AVIR
$267M
| $8.33M | 0.87% | 2,485,638 | – | – |
|
|
16
Cidara Therapeutics
CDTX
$1.66B
| $7.56M | 0.79% | +703,080 | New | +$7.56M |
|
17
Rapid Micro Biosystems
RPID
$107M
| $7.51M | 0.78% | 8,434,560 | – | – |
|
18
C4 Therapeutics
CCCC
$185M
| $6.34M | 0.66% | 1,111,910 | – | – |
|
|
SYRS
19
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $5.91M | 0.62% | 2,750,151 +343 | +0% | +$737 |
|
20
Nautilus Biotechnolgy
NAUT
$85.9M
| $5.7M | 0.59% | 2,000,000 | – | – |
|
|
MRNS
21
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $4.74M | 0.49% | 2,693,380 +425,700 | +19% | +$749K |
|
|
22
Xilio Therapeutics
XLO
$36.3M
| $3.6M | 0.37% | 4,566,817 +781,367 | +21% | +$615K |
|
23
Invivyd
IVVD
$204M
| $1.84M | 0.19% | 1,799,595 | – | – |
|
|
24
NewAmsterdam Pharma Company N.V. Warrant
NAMSW
$58.3M
| $700K | 0.07% | 100,000 | – | – |
|
|
25
Aclaris Therapeutics
ACRS
$209M
| – | – | -1,000,000 | Closed | -$1.1M |
|